(Q44546671)

4 December 2017

title

Lipid-lowering drugs and serum liver enzymes: the effects of body weight and baseline enzyme levels (English)

1 reference

4 December 2017

Dimitrios N Kiortsis

1

1 reference

4 December 2017

Spyridon Nikas

2

1 reference

4 December 2017

Katerina Hatzidimou

3

1 reference

4 December 2017

Epaminondas Tsianos

4

1 reference

4 December 2017

Moses S Elisaf

5

1 reference

4 December 2017

publication date

1 August 2003

1 reference

Fundamental and Clinical Pharmacology

4 December 2017

published in

1 reference

4 December 2017

volume

17

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

491-494

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00176.X

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00176.X

Nonalcoholic Steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00176.X

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00176.X

Current perspectives on statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00176.X

Prevalence of and risk factors for hepatic steatosis in Northern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00176.X

Efficacy of combination of atorvastatin and micronised fenofibrate in the treatment of severe mixed hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00176.X

10.1046/J.1472-8206.2003.00176.X

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference